Lenovo updates its Legion and LOQ gaming laptops for CES
Lenovo has made a host of updates to its Legion and LOQ line of gaming laptops for CES 2026. The refreshed laptops are all built around Nvidia RTX 50 series GPUs.
The new Legion 7a is both thinner and lighter than the previous generation and is aimed at gamers, creators and working professionals. Lenovo says the new 7a will be powered by RTX 50-series GPUs, offering up to 125W of total system power.
Presumably, this means buyers will choose from multiple CPU and GPU configurations, and Lenovo says the 7a will support up to a Ryzen AI 9 HX 470 and up to an RTX 5060 GPU, but precise details on other configurations have not been made available.
The laptop features a 16-inch OLED display and Lenovo claims that the laptop’s “AI-optimized” performance is ready to handle complex coding, simulation and 3D modeling projects. The 7a runs Windows 11 Copilot+ and uses built-in software to dynamically adjust power consumption and temperatures based on the laptop’s workload. Legion 7a will start at $2,000, with availability “expected” in April.
Lenovo is also refreshing the Legion 5 lineup with the new-powered Legion 5i and the Legion 5a with a choice of an AMD Ryzen AI 400 or Ryzen 200. Both will offer RTX 50 series GPUs, OLED displays, and the same software tuning features as the 7a. Lenovo says the 5i can be up to an Intel Ultra 9 386H with an RTX 5060 GPU, and the 5a up to a Ryzen AI 9 465 with RTX 5060. Again, we don’t have details on alternative configurations yet.
The Legion 5 laptops run Windows 11 Copilot+, and Lenovo says they’re ready for gaming, streaming, creating presentations, and video editing. Pricing starts at $1,550 for the 5i, $1,500 for the 5a with Ryzen AI 400, and $1,300 for the 5a with Ryzen 200. Lenovo also expects these laptops to be available in April.
At the entry level, the LOQ 15AHP11 and LOQ 15IPH11 target students with RTX 50-series graphics and up to 15.3-inch WQXGA (2560 x 1600) LCD. The 15AHP11 will start at $1,150 and be available in April, while the 15IPH11 will not be sold in the United States.
